Loading clinical trials...
Loading clinical trials...
This study aims to classify adult-onset diabetes patients into distinct data-driven clusters, such as severe insulin-deficient, severe insulin-resistant, mild obesity-related, and mild age-related dia...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Getz Pharma
NCT07224321 · Type 1 Diabetes Mellitus
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT07340320 · Type II Diabetes Mellitus
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT07222137 · Diabetes Mellitus, Type 1
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions